Atlas Trials

MAXVAX Biotechnology Limited Liability Company

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MAXVAX Biotechnology Limited Liability Company

RecordFirmDate
A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) (NCT07618325)MAXVAX Biotechnology Limited Liability Company2026-06-02
Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women (NCT07492706)MAXVAX Biotechnology Limited Liability Company2026-04-01
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) (NCT07293065)MAXVAX Biotechnology Limited Liability Company2025-12-15
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) (NCT07272434)MAXVAX Biotechnology Limited Liability Company2025-10-22
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell). (NCT06654700)MAXVAX Biotechnology Limited Liability Company2024-12-09
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above (NCT06642558)MAXVAX Biotechnology Limited Liability Company2024-11-13
Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above (NCT05856084)MAXVAX Biotechnology Limited Liability Company2023-05-07
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above (NCT05636436)MAXVAX Biotechnology Limited Liability Company2022-12-07

Track MAXVAX Biotechnology Limited Liability Company automatically

Every clearance here is in the API, with alerts when new ones post.